INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-90 Cr | ₹-71 Cr | ₹-67 Cr | ₹-69 Cr | ₹-37 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDEGENE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-90 Cr |
Mar2024 | ₹-71 Cr |
Mar2023 | ₹-67 Cr |
Mar2022 | ₹-69 Cr |
Mar2021 | ₹-37 Cr |
How is Deferred Tax Assets / Liabilities of INDEGENE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-90 Cr | Negative | |
Mar2024 | ₹-71 Cr | Negative | |
Mar2023 | ₹-67 Cr | Negative | |
Mar2022 | ₹-69 Cr | Negative | |
Mar2021 | ₹-37 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹14,085.5 Cr | 2.3% | 1.3% | -14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 2.3% |
1.3% |
-14% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses